Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 30,000 shares at $17.00 ($510K) on 2024-09-10, disclosed to the SEC on 2024-09-12.
Scheduled sale ($510k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |